Speaker illustration

Professor Christopher Miller

University of Manchester, Manchester (United Kingdom of Great Britain & Northern Ireland)

State-of-the art treatment of HFmrEF and HFpEF in 2023

Event: ESC Congress 2023

Topic: Treatment

Session type: Advances in Science

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb